The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(3-(3-Chloro-5-((4-(trifluoromethyl)oxazol-5-yl)methoxy)phenyl)-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione ID: ALA4873590
PubChem CID: 164623930
Max Phase: Preclinical
Molecular Formula: C25H15ClF3N5O5
Molecular Weight: 557.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]cc(-c2cc(-c3cc(Cl)cc(OCc4ocnc4C(F)(F)F)c3)c(=O)n(-c3cccnc3)c2)c(=O)[nH]1
Standard InChI: InChI=1S/C25H15ClF3N5O5/c26-15-4-13(5-17(7-15)38-11-20-21(25(27,28)29)32-12-39-20)18-6-14(19-9-31-24(37)33-22(19)35)10-34(23(18)36)16-2-1-3-30-8-16/h1-10,12H,11H2,(H2,31,33,35,37)
Standard InChI Key: BZOQLNKQJLJRJD-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
11.7557 -2.8726 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.5443 -2.0767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9603 -2.6598 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.7150 -6.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7138 -6.8543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4291 -7.2692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1419 -6.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1390 -6.0235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4273 -5.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0020 -5.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0032 -4.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2891 -4.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5732 -4.7915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5761 -5.6207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2908 -6.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8494 -5.6117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5662 -6.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2791 -5.6087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2764 -4.7830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5549 -4.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8450 -4.7902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4308 -8.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7141 -8.5015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7136 -9.3256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4289 -9.7411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1422 -9.3224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1393 -8.4996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8627 -6.0336 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.4249 -4.7916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2893 -3.5519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0043 -3.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0045 -2.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6693 -1.8277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4118 -1.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5868 -1.0427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3331 -1.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9997 -8.0903 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4298 -10.5661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9345 -1.5313 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 10 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 16 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 22 2 0
6 22 1 0
14 28 1 0
9 29 2 0
12 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 2 0
35 36 1 0
36 32 2 0
36 2 1 0
23 37 2 0
25 38 2 0
2 39 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.87Molecular Weight (Monoisotopic): 557.0714AlogP: 4.18#Rotatable Bonds: 6Polar Surface Area: 135.87Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.81CX Basic pKa: 4.22CX LogP: 2.08CX LogD: 2.06Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.32Np Likeness Score: -1.05
References 1. Zhang CH, Spasov KA, Reilly RA, Hollander K, Stone EA, Ippolito JA, Liosi ME, Deshmukh MG, Tirado-Rives J, Zhang S, Liang Z, Miller SJ, Isaacs F, Lindenbach BD, Anderson KS, Jorgensen WL.. (2021) Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency., 12 (8.0): [PMID:34408808 ] [10.1021/acsmedchemlett.1c00326 ]